Evidence map›Paper›PMID 33688501›Full record

Trial reportBioMed research international2021

A Prediction Model for Cognitive Impairment Risk in Colorectal Cancer after Chemotherapy Treatment.

Shu-Ping Zhou, Su-Ding Fei, Hui-Hui Han, Jing-Jing Li, Shuang Yang, Chun-Yang Zhao

RetractedOpen access · hybridAbstract readClinical TrialRetracted Publication
In one paragraph

Trial report in BioMed research international, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It has been retracted, and should not be counted. Cited by 13 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 1 pooled it
2.8field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 1 synthesis or guideline pooled it, 21 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Social determinants of health, diet, and symptom experiences in colorectal cancer survivors: A scoping review.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2025
    Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Shu-Ping ZhouNingbo College of Health Sciences, No. 51, Xuefu Road, Yinzhou, Ningbo 315100, China.
Su-Ding FeiNingbo College of Health Sciences, No. 51, Xuefu Road, Yinzhou, Ningbo 315100, China.ORCID https://orcid.org/0000-0002-3013-6086
Hui-Hui HanNingbo College of Health Sciences, No. 51, Xuefu Road, Yinzhou, Ningbo 315100, China.
Jing-Jing LiNingbo College of Health Sciences, No. 51, Xuefu Road, Yinzhou, Ningbo 315100, China.
Shuang YangNingbo College of Health Sciences, No. 51, Xuefu Road, Yinzhou, Ningbo 315100, China.
Chun-Yang ZhaoNingbo College of Health Sciences, No. 51, Xuefu Road, Yinzhou, Ningbo 315100, China.
Ningbo College of Health Sciences · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundA prediction model can be developed to predict the risk of cancer-related cognitive impairment in colorectal cancer patients after chemotherapy.

methodsA regression analysis was performed on 386 colorectal cancer patients who had undergone chemotherapy. Three prediction models (random forest, logistic regression, and support vector machine models) were constructed using collected clinical and pathological data of the patients. Calibration and ROC curves and

resultsThree prediction models including a random forest, a logistic regression, and a support vector machine were constructed. The logistic regression model had the strongest predictive power with an area under the curve (AUC) of 0.799. Age, BMI, colostomy, complications, CRA, depression, diabetes, QLQ-C30 score, exercise, hypercholesterolemia, diet, marital status, education level, and pathological stage were included in the nomogram. The

conclusionsA prediction model with good predictive ability and practical clinical value can be developed for predicting the risk of cognitive impairment in colorectal cancer after chemotherapy.

Indexed as

Cognitive DysfunctionColorectal NeoplasmsModels, BiologicalAgedFemaleHumansMaleMiddle AgedNomogramsPredictive Value of Tests

Identifiers

PMID33688501
PMCPMC7914097
OpenAlexW3129538348

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.